STOCKHOLM–UPPSALA: A world-class centre of life
... disease and neurodegenerative diseases. Two programmes that have received particular interest are cell therapy research at Uppsala University and the Human Regenerative Map, a collaboration between Karolinska Institutet and Uppsala University. Research within Cardiovascular diseases is carried out w ...
... disease and neurodegenerative diseases. Two programmes that have received particular interest are cell therapy research at Uppsala University and the Human Regenerative Map, a collaboration between Karolinska Institutet and Uppsala University. Research within Cardiovascular diseases is carried out w ...
PRESS RELEASE
... Ipsen is a global specialty-driven pharmaceutical group with total sales exceeding €1.4 billion in 2015. Ipsen sells more than 20 drugs in more than 115 countries, with a direct commercial presence in more than 30 countries. Ipsen’s ambition is to become a leader in specialty healthcar ...
... Ipsen is a global specialty-driven pharmaceutical group with total sales exceeding €1.4 billion in 2015. Ipsen sells more than 20 drugs in more than 115 countries, with a direct commercial presence in more than 30 countries. Ipsen’s ambition is to become a leader in specialty healthcar ...
Infectious Diseases Report World-Leading Research and Business
... into infectious diseases becomes even more puzzling. The Stockholm-Uppsala region differs in this regard. It has several awarding bodies that support pre-clinical science, observational studies, clinical trials, and translational research – not least within the field of infectious diseases. This goe ...
... into infectious diseases becomes even more puzzling. The Stockholm-Uppsala region differs in this regard. It has several awarding bodies that support pre-clinical science, observational studies, clinical trials, and translational research – not least within the field of infectious diseases. This goe ...
